New Era in Refractory Immune Thrombocytopenia | Diana Byrnes, MD, MPH

Diana Byrnes, MD, MPH
Assistant Professor of Clinical Medicine
University of Miami

Dr. Byrnes is an assistant professor on the Clinical Educator track in the Department of Medicine, Division of Hematology at the Sylvester Comprehensive Cancer Center/University of Miami Miller School of Medicine. Her focus is on benign hematology, with research interests in women’s health and cancer-associated thrombosis. Dr. Byrnes has a deep passion for benign hematology, appreciating the challenging clinical scenarios it presents, many of which can become life-threatening if not identified and managed promptly.

One of the primary reasons Dr. Byrnes chose to stay in academic medicine is the rewarding experience of training medical students, residents, and fellows. During her fellowship, she organized quarterly benign hematology symposiums addressing complex topics such as the management of thrombotic thrombocytopenic purpura and an overview of bleeding disorders in women. Since joining the faculty, Dr. Byrnes has remained active in education by providing lectures to fellows during academic half days and organizing bi-weekly benign hematology conferences focused on clinically challenging cases. She also delivers an annual presentation on hematologic disorders in pregnancy for Dr. Gerald Soff’s Hematology Education Online lecture series, targeting medical trainees both nationally and internationally.

In terms of research, Dr. Byrnes is dedicated to launching multi-center, collaborative clinical trials that could lead to practice-changing advancements in benign hematology. She serves as the primary investigator for a phase III trial investigating a novel anticoagulant targeting factor XI in cancer-associated thrombosis. Additionally, Dr. Byrnes has a strong interest in women’s health within hematology, recognizing it as an area with significant unmet needs. Through her collaborative research efforts, she aims to become a locally and nationally recognized expert in the management of complex non-malignant hematology.

JOIN HERE!

Dr. Byrnes’ Objectives:

At the end of the presentation, participants will be able to do the following

• Analyze available second and third-line treatment options for ITP
• Assess promising novel therapies in development
• Assess treatment options for refractory ITP in pregnancy

Faculty Disclosure

Dr. Byrnes has indicated that he/she has the following financial relationships with commercial interests.

Ineligible Company/Role

Sanofi/ Advisor

Anthos/ Researcher

Planning Committee Disclosure

Dr. Lekakis has indicated that he has no relevant financial relationships with commercial interests.

Target Audience

Faculty, Primary Care Physicians, APRNs, PharmD

Accreditation

The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.